Form 4: Aethelon Medical Director Reports Stock Transaction

Aethelon Medical Inc. director Edward G. Broenniman reported a transaction involving the forfeiture of 1,091 shares of common stock to cover tax withholdings.

Summary

• Edward G. Broenniman, a Director at Aethelon Medical Inc. (AEMD), reported a transaction on June 30, 2026.
• The transaction involved the forfeiture of 1,091 shares of common stock.
• This forfeiture was to cover tax withholdings upon the conversion of 5,454 vested restricted stock units (RSUs) into common stock.
• The value used for the forfeiture was the market price of the issuer's common stock at the time of forfeiture, which was $0.82 per share.
• These RSUs were part of a grant previously reported on April 17, 2026.
• Following this transaction, Mr. Broenniman directly beneficially owns 22,363 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports a standard administrative transaction related to equity compensation rather than a significant strategic event or financial performance indicator.

Positives

• Director Edward G. Broenniman continues to hold a significant direct beneficial ownership of 22,363 shares of Aethelon Medical Inc. common stock.
• The forfeiture of shares for tax withholding is a standard procedure that ensures compliance without requiring out-of-pocket payment from the director.

Negatives

• A net of 1,091 shares were forfeited by the director, reducing his direct share count.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing, which solely reports a past transaction.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures for insiders and reflect standard corporate actions like tax withholding on equity awards, rather than strategic shifts. The transaction details are specific to Aethelon Medical Inc. and do not immediately indicate broader industry trends.

Stakeholder Impact

• Shareholders: The transaction does not directly impact the total number of outstanding shares, but it reflects the cost of compensation for management in the form of equity dilution or cash outflow for taxes.

Key Dates

Keywords

Aethelon Medical Inc., AEMD, Form 4, SEC Filing, Stock Transaction, Director, Beneficial Ownership, Restricted Stock Units, Tax Withholding, Forfeiture